Endocrine News and Research

RSS

Brazilian professors propose guidelines for therapeutic use of melatonin

Sixty years after melatonin was isolated and with more than 23,000 published studies showing the many functions of this hormone secreted by the pineal gland, guidelines should be discussed and established for its therapeutic use.

11 Dec 2018

Study: Some people with Type 2 diabetes may be testing their blood sugar more often than needed

For people with Type 2 diabetes, the task of testing their blood sugar with a fingertip prick and a drop of blood on a special strip of paper becomes part of everyday life.

11 Dec 2018

New data from TAILORx trial confirms lack of chemo benefit regardless of race or ethnicity

An analysis of race and ethnicity data from the TAILORx clinical trial was presented at the 2018 San Antonio Breast Cancer Symposium.

10 Dec 2018

Exercise program during adjuvant breast cancer treatment may provide cardiovascular benefits

Women who underwent a supervised program of cardiovascular exercise during adjuvant breast cancer treatment experienced better cardiovascular function than those who were not part of the exercise program, according to results of the EBBA-II trial presented at the 2018 San Antonio Breast Cancer Symposium, held Dec. 4-8.

7 Dec 2018

Study reveals possible link between hysterectomy and brain function

A new preclinical study has shown that in the short term, some types of memory are affected following a hysterectomy.

7 Dec 2018

Scientists support original theory about pancreas regeneration

A contentious debate among diabetes researchers has surrounded the regeneration of pancreatic insulin-producing cells: not if these cells regenerate, but rather how.

5 Dec 2018

Weight cycling could increase a person's risk of death, study shows

Weight cycling is associated with a higher risk of death, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

29 Nov 2018

New strategy for developing cell replacement therapies to combat type 1 diabetes

Scientists have discovered the signals that determine the fate of immature cells in the pancreas. The research shows that they are very mobile and that their destiny is strongly influenced by their immediate environment.

29 Nov 2018

Study suggests possible vulnerability to evening stress

Stressful events in the evening release less of the body's stress hormones than those that happen in the morning, suggesting possible vulnerability to stress in the evening.

27 Nov 2018

Experts debate over whether gut or brain is more important in regulating appetite

Whether gut or brain hormones are more important for the regulation of appetite and metabolism is not clearly defined. Imbalances in the control of appetite and metabolism can lead to obesity and diabetes, which have a negative impact on people's health and healthcare costs.

19 Nov 2018

Endocrine Society chooses four Diabetes Caucus leaders as winners of Diabetes Champion Award

The Endocrine Society today announced it has chosen Senator Susan Collins, Representative Tom Reed, Senator Jeanne Shaheen, and Representative Diana DeGette of the Congressional Diabetes Caucus as winners of its prestigious Diabetes Champion Award.

15 Nov 2018

New project aims to estimate scientific basis of health risks posed by substance mixtures

The BfR is involved with two work groups in the project, which is being coordinated by the Dutch National Institute for Public Health and the Environment

1 Nov 2018

Unraveling a rare genetic mutation related to growth disorders

What would happen if you suddenly stopped growing at age 12 or 13? Solving genetic growth mysteries and scheduling regular appointments with pediatric endocrinologists is atypical for most parents and pediatricians.

1 Nov 2018

Head and neck cancer survivors more likely to commit suicide

Despite improved survival rates among cancer patients, the risk of death by suicide remains high, especially among those treated for head and neck cancers.

25 Oct 2018

Biomarkers can predict treatment response in women with endometriosis

Biomarkers can predict whether women will respond to the first-line treatment for endometriosis, an extremely painful condition in which the tissue usually found inside the uterus grows in places it shouldn't, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

24 Oct 2018

New approach using 'cellular dust' offers hope for regenerative medicine

While stem cells have the most therapeutic potential, the benefits of regenerative medicine may best be mobilized using extracellular vesicles (EVs), also known in the past as "cellular dust".

24 Oct 2018

Study reveals new treatment option for women with advanced breast cancer resistant to hormone therapy

Treatment with the cyclin dependent kinase 4/6 inhibitor palbociclib achieves a clinically meaningful improvement in overall survival in patients with hormone receptor positive human epidermal growth factor receptor-2 negative advanced breast cancer that has relapsed or progressed on hormonal therapy, according to the final analysis of overall survival results from the PALOMA-3 study reported at ESMO 2018.

23 Oct 2018

Drugs approved for breast cancer treatment are effective and well tolerated in men

There is growing evidence that drugs approved for the treatment of breast cancer in women are also effective and well tolerated in men, according to the largest real-life study yet to investigate treatment and outcomes in men with breast cancer and two further studies to be reported at ESMO 2018.

23 Oct 2018

Study: Targeting specific genomic mutation in breast cancer improves survival

Targeting a common mutation in patients with hormone receptor positive (HR+) HER2 negative (HER2-) advanced breast cancer with the alpha-specific phosphatidylinositol-3-kinase (PI3K) inhibitor alpelisib significantly improves progression-free survival, according to late-breaking results reported at ESMO 2018.

22 Oct 2018

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Pfizer Inc. today announced detailed overall survival data from the PALOMA-3 trial, which evaluated IBRANCE (palbociclib) in combination with fulvestrant compared to placebo plus fulvestrant in women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer whose disease progressed on or after prior endocrine therapy.

22 Oct 2018

Endocrine News and Research

Brazilian professors propose guidelines for therapeutic use of melatonin

Study: Some people with Type 2 diabetes may be testing their blood sugar more often than needed

New data from TAILORx trial confirms lack of chemo benefit regardless of race or ethnicity

Exercise program during adjuvant breast cancer treatment may provide cardiovascular benefits

Study reveals possible link between hysterectomy and brain function

Scientists support original theory about pancreas regeneration

Weight cycling could increase a person's risk of death, study shows

New strategy for developing cell replacement therapies to combat type 1 diabetes

Study suggests possible vulnerability to evening stress

Experts debate over whether gut or brain is more important in regulating appetite

Endocrine Society chooses four Diabetes Caucus leaders as winners of Diabetes Champion Award

New project aims to estimate scientific basis of health risks posed by substance mixtures

Unraveling a rare genetic mutation related to growth disorders

Head and neck cancer survivors more likely to commit suicide

Biomarkers can predict treatment response in women with endometriosis

New approach using 'cellular dust' offers hope for regenerative medicine

Study reveals new treatment option for women with advanced breast cancer resistant to hormone therapy

Drugs approved for breast cancer treatment are effective and well tolerated in men

Study: Targeting specific genomic mutation in breast cancer improves survival

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News